Overall rank by patents
#41,766
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 13 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Mitsui holds 6 US patents across 13 technology areas, rank #41,766 of 50,000 tracked assignees.
Mitsui Sugar Co., Ltd. has been granted 6 US utility patents between 2015 and 2024, placing Mitsui Sugar Co., Ltd. at rank #41,766 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.0 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Mitsui Sugar Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Mitsui sits between Mitralix Ltd. (6 patents, rank #41,762) and Mobile Video Computing Solutions Llc (6 patents, rank #41,770) - the closest US assignees by grant volume. The composite Innovation Score of 41.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 4 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mitsui Sugar Co., Ltd.'s 14.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mitsui Sugar Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mitralix Ltd.
6 patents
Mitrassist Medical Ltd.
6 patents
Mitsubishi Kagaku Imaging Corporation
6 patents
Mitsui Chemicals Crop & Life Solutions, Inc.
6 patents
Moberg Pharma AB
6 patents
Mobile I.V. Systems, LLC
6 patents
Mobile Research Labs, Ltd.
6 patents
Mobile Video Computing Solutions LLC
6 patents
Mitsui Sugar Co., Ltd.
6 patents
What this shows Mitsui holds 6 patents at rank #41,766, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,766 in granted patent volume.
Other assignees with the most granted patents in Mitsui's primary technology class.
Mitsui's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2017 | 2 | 33.3% |
| 2024 | 2 | 33.3% |
Top 13 of 13 technology areas
Overall rank by patents
#41,766
Across all tracked assignees
41.2 out of 100
How to use this portfolio
Mitsui's 6 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.